2BBBullish & Bearish
Becton, Dickinson and Company Common Stock (BDX) trades on NYSE. It operates in the Health Care sector, Medical Instruments & Supplies industry. Its current 2BB score is 44 out of 100.
Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas. BD is ranked #211 in the 2024 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2023.
Becton, Dickinson and Company Common Stock’s current 2BB score is 44 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 27 | Low |
| Momentum | 38 | Weakening |
| Financial strength | 69 | Strong |
| Quality | 100 | Very Strong |
| Risk | 33 | Low |
| CEO | Thomas Polen |
| Headquarters | Franklin Lakes, New Jersey, United States |
| Founded | 1897 |
| Employees | 72K |
| P/E ratio | 56.83 |
| 52-week range | $127.54 – $193.07 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-08 | — | 2.7553 | — | $4.62B |
| 2026-11-02 | — | 4.1059 | — | $5.17B |
| 2026-08-06 | — | 3.1728 | — | $4.94B |
| 2026-05-07 | 2.9 | 2.8027 | $4.71B | $4.72B |